238 related articles for article (PubMed ID: 32495879)
1. LncNORAD interference inhibits tumor growth and lung cancer cell proliferation, invasion and migration by down-regulating CXCR4 to suppress RhoA/ROCK signaling pathway.
Wu Y; Shen QW; Niu YX; Chen XY; Liu HW; Shen XY
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5446-5455. PubMed ID: 32495879
[TBL] [Abstract][Full Text] [Related]
2. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
[TBL] [Abstract][Full Text] [Related]
3. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
4. MiroRNA-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1).
Zeng X; Liu D; Peng G; Liu J; Yang H
Comput Math Methods Med; 2022; 2022():4597087. PubMed ID: 35126623
[TBL] [Abstract][Full Text] [Related]
5. Silencing the long noncoding RNA NORAD inhibits gastric cancer cell proliferation and invasion by the RhoA/ROCK1 pathway.
Yu SY; Peng H; Zhu Q; Wu YX; Wu F; Han CR; Yan B; Li Q; Xiang HG
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3760-3770. PubMed ID: 31115002
[TBL] [Abstract][Full Text] [Related]
6. Silencing of Long Non-Coding RNA (LncRNA) Non-Coding RNA Activated by DNA Damage (NORAD) Inhibits Proliferation, Invasion, Migration, and Promotes Apoptosis of Glioma Cells via Downregulating the Expression of AKR1B1.
Luo L; Chen C; He H; Cai M; Ling C
Med Sci Monit; 2020 Jul; 26():e922659. PubMed ID: 32778640
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of long non-coding RNA XIST inhibits cell proliferation, migration, invasion and EMT by regulating miR-212-3p/CBLL1 axis in non-small cell lung cancer cells.
Qiu HB; Yang K; Yu HY; Liu M
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8391-8402. PubMed ID: 31646569
[TBL] [Abstract][Full Text] [Related]
8. NORAD regulates epithelial‑mesenchymal transition of non‑small cell lung cancer cells via miR‑422a.
Chen Z; Che Q; Xie C
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300080
[TBL] [Abstract][Full Text] [Related]
9. LncRNA NORAD, sponging miR-363-3p, promotes invasion and EMT by upregulating PEAK1 and activating the ERK signaling pathway in NSCLC cells.
Geng Q; Li Z; Li X; Wu Y; Chen N
J Bioenerg Biomembr; 2021 Jun; 53(3):321-332. PubMed ID: 33742335
[TBL] [Abstract][Full Text] [Related]
10. LncRNA HOTAIR promotes proliferation, invasion and migration in NSCLC cells via the CCL22 signaling pathway.
Liang H; Peng J
PLoS One; 2022; 17(2):e0263997. PubMed ID: 35176085
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
[TBL] [Abstract][Full Text] [Related]
12. Long Non-Coding RNAs (lncRNAs) Tumor-Suppressive Role of lncRNA on Chromosome 8p12 (TSLNC8) Inhibits Tumor Metastasis and Promotes Apoptosis by Regulating Interleukin 6 (IL-6)/Signal Transducer and Activator of Transcription 3 (STAT3)/Hypoxia-Inducible Factor 1-alpha (HIF-1α) Signaling Pathway in Non-Small Cell Lung Cancer.
Fan H; Li J; Wang J; Hu Z
Med Sci Monit; 2019 Oct; 25():7624-7633. PubMed ID: 31601776
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion.
Dong YZ; Meng XM; Li GS
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2671-2679. PubMed ID: 29771418
[TBL] [Abstract][Full Text] [Related]
15. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer.
Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
17. Linc8087 predicts favorable prognosis and inhibits cell migration and invasion in NSCLC.
Qi Q; Chen C; Liu C; Zhang B; Ma Y; Zhang H; Huang W; Wang C
Pathol Res Pract; 2021 Sep; 225():153569. PubMed ID: 34391179
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA ASAP1-IT1 promotes cell proliferation, invasion and metastasis through the PTEN/AKT signaling axis in non-small cell lung cancer.
Zhang L; Shi SB; Zhu Y; Qian TT; Wang HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):142-149. PubMed ID: 29364481
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.
Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B
Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972
[TBL] [Abstract][Full Text] [Related]
20. IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
Panneerselvam J; Jin J; Shanker M; Lauderdale J; Bates J; Wang Q; Zhao YD; Archibald SJ; Hubin TJ; Ramesh R
PLoS One; 2015; 10(3):e0122439. PubMed ID: 25775124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
